| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus |
0.25 |
0.25 |
0.12 － 0.5 |
Levofloxacin (Levaquin, Quixin) |
244 |
| Staphylococcus aureus |
0.25 |
2 |
0.006 － 2 |
Levofloxacin (Levaquin, Quixin) |
1544 |
| Staphylococcus aureus |
>0.25 |
>4 |
≤0.03 － >4 |
Levofloxacin (Levaquin, Quixin) |
472 |
| Staphylococcus aureus |
>0.25 |
>4 |
≤0.12 － >4 |
Levofloxacin (Levaquin, Quixin) |
1130 |
| Staphylococcus aureus |
>0.25 |
>8 |
≤0.03 － >8 |
Levofloxacin (Levaquin, Quixin) |
108 |
| Staphylococcus aureus |
>4 |
>32 |
≤0.06 － >32 |
Levofloxacin (Levaquin, Quixin) |
42 |
| Staphylococcus aureus |
- |
- |
0.12 － ? |
Levofloxacin (Levaquin, Quixin) |
1121 |
| Staphylococcus aureus |
- |
- |
0.125 － ? |
Levofloxacin (Levaquin, Quixin) |
118 |
| Staphylococcus aureus |
- |
- |
29 － ? |
Levofloxacin (Levaquin, Quixin) |
1132 |
| Staphylococcus aureus |
- |
- |
32 － ? |
Levofloxacin (Levaquin, Quixin) |
1323 |
| Staphylococcus aureus (ATCC 1350 + clindamycin-resistant + erythromycin-resistant + peni) |
- |
- |
0.12 － ? |
Levofloxacin (Levaquin, Quixin) |
437 |
| Staphylococcus aureus (ATCC 7702 + chloramphenicol-resistant + ciprofloxacin-resistant +) |
- |
- |
16 － ? |
Levofloxacin (Levaquin, Quixin) |
437 |